Price History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Mixed MA signals — sideways/transition
Price Action
Support & Resistance Levels
Volume Analysis
Recent MA Crossovers
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹702.6 Cr | ₹771.6 Cr | ₹790.2 Cr | ₹800.9 Cr |
| Net Profit | ₹93.5 Cr | ₹118 Cr | ₹120.2 Cr | ₹99.7 Cr |
| EPS | — | ₹8.66 | ₹8.82 | ₹7.32 |
| Operating Profit | ₹260.4 Cr | ₹280.3 Cr | ₹291.3 Cr | ₹264.5 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 29 May 2026 | Interim Dividend - Rs 7.21 Per Share | INTERIM_DIVIDEND |
| 13 Feb 2025 | Interim Dividend - Rs 7.35 Per Share | INTERIM_DIVIDEND |
| 17 Sept 2024 | Annual General Meeting | AGM |
| 15 Sept 2023 | Annual General Meeting | AGM |
| 23 Aug 2022 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ERIS
View All
Ipca Laboratories among 5 stocks showing bullish RSI upswing
Five Nifty500 stocks, including Leela Palaces, Eris Lifesciences, Indian Bank, Mankind Pharma, and Ipca Laboratories, showed bullish momentum as their RSI crossed above 50, signaling potential upward price movement.
Epack Durable Ltd leads losers in 'A' group
Jubilant Foodworks Ltd, P I Industries Ltd, JK Lakshmi Cement Ltd and ERIS Lifesciences Ltd are among the other losers in the BSE's 'A' group today, 21 May 2026.
Eris Lifesciences among 5 stocks showing bullish RSI upswing
Five Nifty500 stocks featured in the RSI Trending Up scan on May 20 after gaining over 5%. The RSI moved above the 50 mark from lower levels, signalling improving momentum, strengthening price action, and potential short-term buying opportunities for traders tracking bullish technical setups and momentum-based market trends.